Pfizer to sell Hospira Infusion Systems to ICU Medical
$1bn deal brings together medical device units, as Pfizer focuses on Hospira’s biosimilars and generics
$1bn deal brings together medical device units, as Pfizer focuses on Hospira’s biosimilars and generics